Foundational an overarching view of the material paired with the mechanism enabling it

Domperidone is the active ingredient in products sometimes sold under the tradename Motilium and in generic forms. It acts mainly on dopamine D2 and D3 receptors located outside the central nervous system to promote movement of the upper gut and to relieve nausea and vomiting. Typical tablet strength prescribed in UK practice is 10 mg.

Because domperidone crosses the blood brain barrier only to a small extent, it has a lower incidence of central nervous system adverse impact on health compared with some other antiemetics. However, clinicians monitor for potential effects on heart rhythm and for user a reciprocal exchanges drive engagement and learning. that may raise domperidone blood levels.

Quick access links from here: dosing details are at methods for taking and dosing., alerts about collaborative interaction at interacting with others profiles for drugs, and a cost summary at price analysis guide in the UK.

Clinical rationale for administration and applications

In the United Kingdom domperidone is typically given for short-term control of nausea and vomiting. It is licensed primarily for these symptoms, while use for delayed gastric emptying or other motility problems is at the prescriber's discretion.

Common clinical scenarios where domperidone may be used include:

• Acute nausea and vomiting from a variety of causes where short-term symptom control is needed.
• As part of specialist regimens to help patients tolerate different treatments, for example some chemotherapy protocols, under direct supervision.
• When delayed gastric emptying is suspected to be contributing to symptoms and increased gastric motility may help.
• In selected diagnostic or therapeutic procedures that require enhanced upper gut motility, instructed by a specialist.

Always follow the directions of the prescriber. Look over the dosing specifics consult the details for specifics. clinical guidance on dosing.

How to take efficiently and manage dosing

Take domperidone exactly as instructed by your doctor or pharmacist. Tablets are often taken shortly before meals to improve effectiveness.

Adults and adolescents

For those aged 12 years and older and weighing more than 35 kg, typical regimens are:

• Standard dose: 10 mg up to three times a day, given before food.
• Common maximum daily dose: 30 mg.
• Short courses are usual for acute problems; many clinicians limit initial use to 7 days unless a specialist recommends longer treatment.

Minors and special populations

Tablets are not generally recommended for children under 12 years or under 35 kg except on specialist advice. Liquid formulations, when available, require dosing by a specialist or pharmacist.

Renal and hepatic status considerations

• Severe renal impairment may prolong elimination; a prescriber may reduce the dose or dosing frequency and should review long term use.
• Moderate to severe hepatic impairment is a contraindication; domperidone should not be used in these cases.

Dose left untaken

If you skip a dose, take it when you remember unless the next scheduled dose is due soon. Never take two doses at once to make up for a dose you missed.

Excipients and product notes

Some domperidone products contain lactose. If you have lactose intolerance, glucose-galactose malabsorption, or related hereditary conditionskindly check this. with your pharmacist for an a new possibility formulation. See safety a bird's eye view of the capstoneic and contraclues to adopt further protective steps.

Store and handle

• Keep the medicine in its original container and store at 20 to 25 C (68 to 77 F) unless the leaflet instructs otherwise.
• Protect from extreme heat, moisture and direct sunlight.
• Do not store in bathrooms or other damp rooms.
• Ensure medicines are kept away from kids and animals and out of sight.

Safety rules and situations in which therapy is not appropriate

Do not use domperidone if any of the following apply:

• Known hypersensitivity to domperidone or any component of the product.
• Moderate or severe liver disease.
• Known prolonged QT interval, significant heart disease, or a history of ventricular arrhythmia.
• Concomitant use of medicines that strongly prolong QT or strong CYP3A4 inhibitors; see drug and drug a reciprocal exchange risk warnings by way of illustration.
• Conditions where increasing gut motility could be harmful such as active gastrointestinal bleeding, perforation, or mechanical obstruction.
• Known pituitary tumor secreting prolactin such as prolactinoma.

Exercise caution if you have low potassium or magnesium, severe kidney problems, or other factors that increase arrhythmia risk. Seek immediate medical help for fainting, sudden severe dizziness, or palpitations.

Drug the act of engaging in dialogue management

Various medicines can affect domperidone concentrations or increase cardiac risk. Always inform your clinician about all prescription drugs, over-the-counter products and herbal preparations you use.

Medicines that may reduce its effect

• Antimuscarinic drugs such as hyoscine, procyclidine, tolterodine, oxybutynin and propantheline can slow gut transit and may counteract domperidone.
• Strong opioid analgesics like morphine and codeine also slow gastrointestinal motility and can reduce the prokinetic effect.

Medicines that increase domperidone levels or cardiac risk

• Strong CYP3A4 inhibitors: some azole antifungals (for example ketoconazole, itraconazole), certain macrolide antibiotics (erythromycin, clarithromycin), some HIV protease inhibitors, and some calcium channel blockers such as verapamil and diltiazem.
• Medications known to prolong the QT interval, including some antiarrhythmics, antipsychotics and certain antidepressants; combining these can raise the risk of serious heart rhythm disturbances.

The roster is not exhaustive. Before you commence any new drugplease confirm. with your prescriber or pharmacist. Additional reading safety related situations where this treatment is not advised.

Expecting mothers and breastfeeding mothers

• Pregnancy: data are limited. Domperidone should be used in pregnancy only if the potential benefit justifies the possible risk to the fetus; discuss in partnership with your clinician.
• Breastfeeding: small quantities pass into breast milk. Routine use to boost milk supply is not generally recommended in the UK because of cardiac safety concerns; specialist supervision is required if it is considered.

Tell your healthcare professional if you are pregnant, planning pregnancy, or breastfeeding. Regard the safety section for more details at safety and contraindication notes.

Unintended effects to stay aware of

Most users do not experience serious problems. When adverse reactions occur they are frequently mild. Contact medical services immediately if you develop signs suggesting a cardiac event such as sudden fainting, severe lightheadedness, or a fast irregular heartbeat.

Common or reported reactions

• My mouth is dry, a severe headache, abdominal cramps or diarrhoea.
• Raised prolactin which can rarely lead to breast enlargement, unexpected lactation or changes in menstruation.

Less overused and rare reactions

• Decreased sexual desire, more often reported in men.
• Skin allergic reactions including urticaria.
• Movement disorders such as tremor or stiffness; these are uncommon but may occur.

If you notice worrying effects, contact your prescriber or pharmacist. For the mutual influence during contact warning notices see cross pharmacologic drug effective collaborative interactions require clear communication..

Alternative choices and comparisons

Choice of an another route depends on the cause of nausea, other medical conditions and risk of harmful the dynamics of interaction. A pharmacist or clinician can advise on the best option. Popular substitutes include:

• Metoclopramide: an effective antiemetic and prokinetic but with higher risk of central adverse effects and extrapyramidal symptoms; usually used for short durations.
• Prochlorperazine: available in oral and buccal forms; useful for some migraine or vestibular causes of nausea but can cause sedation or movement reactions.
• Cyclizine: often used for motion sickness and postoperative nausea; commonly causes drowsiness.
• Ondansetron: a 5-HT3 antagonist used in chemotherapy and postoperative settings; may lead to constipation and in some cases affects QT interval.
• Low dose erythromycin (off-label): works on motilin receptors to speed gastric emptying but has notable the dynamic of social contact potential and can cause cramps.

Discuss relative benefits, adverse reactions and costs with your pharmacist. See a short price comparison across products at UK price handbook.

The UK price reference guide

Private prices vary by manufacturer, pharmacy and whether purchased in store or online. The estimates below are approximate and shown in GBP.

• Domperidone 10 mg, pack of 30 generic tablets: about 4 to 10 pounds privately. Branded products such as Motilium, where still available, may cost around 12 to 18 pounds.
• Metoclopramide 10 mg, pack of 28 tablets: roughly 2 to 7 pounds.
• Prochlorperazine buccal 3 mg, pack of 8: commonly 7 to 15 pounds depending on supplier.
• Cyclizine 50 mg, pack of 100 tablets: approximately 5 to 13 pounds for private purchase.
• Ondansetron 4 mg or 8 mg, pack of 10: around 8 to 25 pounds depending on strength and brand.

NHS prescriptions in England normally require a standard charge per item; check current NHS guidance for the precise amount. Prescriptions are generally free in Scotland, Wales and Northern Ireland. Private online consultations and dispensing often add a consultation or service fee, commonly between 10 and 30 pounds in addition to the medicine price.

The legal authorization status of the United Kingdom and purchasing rules

• Domperidone is a Prescription Only Medicine (POM) in the UK and should be supplied only with a valid prescription from an appropriate prescriber.
• Licensed indicators of focus on short-term relief of nausea and vomiting; standard adult dosing is usually 10 mg up to three times daily for up to 7 days unless a clinician advises otherwise.
• Prescribers must consider cardiac risk and maximum potential online the back and forth between peoples connect users across distances. with strong CYP3A4 inhibitors when issuing domperidone; these primary safety guidelines are part of UK prescribing expert counsel.
• If buying online, use pharmacies registered with the General Pharmaceutical Council (GPhC). Verify sellers via the GPhC register and look for legitimate contact details and clear regulatory information has been gathered.
• Importing prescription medicines for personal use without correct documentation may breach MHRA and customs rules. Avoid purchasing from unverified international websites that do not require a prescription.
• If accompanying effects impair your ability to drive or operate machinery, do not drive or use heavy equipment until you are well enough to do so.

For the latest safety alerts consult the Medicines and Healthcare products Regulatory Agency (MHRA) or speak to your pharmacist. Go back to the a quick outline and a device for a summary.

Important update

This page provides general information only and is not a substitute for the patient information leaflet or personalised medical advice. Follow directions from your prescriber and contact a healthcare professional if you have questions. For full product details and a complete list of secondary consequences consult the leaflet or your pharmacist.

To go back to the start of the guide click an executive summary in conjunction with the framework that guides it.